XML 34 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 10, 2020
Feb. 25, 2021
Dec. 31, 2020
May 31, 2021
May 31, 2020
Mar. 31, 2020
Feb. 28, 2021
Mar. 19, 2019
Oct. 01, 2011
Stockholders' Equity Note [Abstract]                  
Issuance of common stock (in Shares)       1,865,000          
Shares of common stock       $ 283,000          
Common stock shares issued         $ 1,358,000        
common stock Value       $ 7,297 235,000   $ 7,111    
Employee Stock Option Plan Description       the Company may grant options for up to 15% of the number of shares of Common Stock of the Company from time to time outstanding, with a contractual option term of five-years, and a vesting period not less than six-months and one day following date of grant. In the three-months ended May 31, 2020, the Board of Directors approved grants of 250,000 stock options to each board member for an aggregate of 1,250,000 options, with an exercise price of $0.25 per option and at a market price of $0.16 on March 19, 2020, the date of grant. On February 25, 2021 and during the fourth quarter of Fiscal 2021, the Board approved the grant of 500,000 stock options to our president with an exercise price of $0.50, vesting in equal increments over a twelve-month period and a five-year contractual term. On December 10, 2020 and during the fourth quarter of Fiscal 2021, the Board approved aggregate grants of 1,000,000 stock options to the four other board members with an exercise price of $0.25, vesting in equal increments over a twelve-month period and a five-year contractual term. The following table provides the assumptions required to apply the Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date: Options Issued During the Three-Months Ended May 31, 2021 Options Issued During the Three-Months Ended February 28, 2021 Exercise Price $0.50 $0.25-$0.50 Share Price $0.27 $0.24-$0.35 Volatility % 226% 226% Risk-Free Rate 0.27% 0.16%-0.34% Expected Term (yrs) 2.80 2.80 Dividend Rate 0% 0% The aggregate fair value of the 1,250,000 options granted in March 2020 is approximately $194,000, or $0.155 per option, with $77,599 recorded as part of sales, general and administration expense during the three months ended May 31, 2020. The aggregate fair value of the 1,500,000 options granted in December 2020 and February 2021 is approximately $382,500, or $0.255 per option, with $146,300 recorded as part of sales, general and administration expense during the three months ended May 31, 2021.          
Stock options Granted                 15.00%
Stock options granted (in Shares)       250,000          
Common stock at price (in Dollars per share)       $ 1,250,000          
Exercise price       $ 0.25          
Market price per share (in Dollars per share)               $ 0.16  
Granted stock options (in Shares) 1,000,000 500,000 1,500,000     1,250,000      
Exercise price of options (in Dollars per share) $ 0.25 $ 0.50   $ 1.40          
Granted stock options, fair value       $ 194,000     $ 382,500    
Stock Options Per Share (in Dollars per share)       $ 0.155     $ 0.255    
Sales, general and administration expense       $ 146,300 $ 77,599